DNA-PK Inhibitor IV MF: C11H13NO3
MW: 207.23
A potent, selective, ATP-competitive DNA-PK inhibitor.

DNA-PK Inhibitor IV

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 97ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
DNA-PK Inhibitor IV is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Nomi alternativi: 2-Hydroxy-4-morpholin-4-yl-benzaldehyde
Applicazione: DNA-PK Inhibitor IV is a potent, selective, ATP-competitive DNA-PK inhibitor
Peso molecolare: 207.23
Formula molecolare: C11H13NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

DNA-PK Inhibitor IV morpholino-salicylaldehyde acts as a potent, selective and ATP-competitive inhibitor of DNA-PK. It inhibits PI 3-K catalytic subunit p110-isozymes at higher concentrations and weakly inhibits a panel of several other kinases. DNA-PK Inhibitor IV is an inhibitor of PI 3-kinase p110 α, PI 3-kinase p110 β and PI 3-kinase p110 δ.


Referenze

1. Kashishian, Adam., et al., 2003. DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Molecular cancer therapeutics. 2(12): 1257-64. PMID: 14707266
2. Willmore, Elaine., et al., 2004. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood. 103(12): 4659-65. PMID: 15010369
3. Knight, Zachary A., et al., 2004. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorganic & medicinal chemistry. 12(17): 4749-59. PMID: 15358300

Stato fisico :
Solid
Solubilità :
Soluble in DMSO (5 mg/ml).
CONSERVAZIONE :
Store at -20° C
Punto di scioglimento :
126.99° C (Predicted)
Punto di ebollizione :
401.3° C at 760 mmHg (Predicted)
Densità :
1.27 g/cm3 (Predicted)
Indice di rifrazione :
n20D 1.61 (Predicted)
IC50 :
DNA-PK: IC50 = 0.43 µM; PI 3-kinase p110 α: IC50 = 10 µM; PI 3-kinase p110 β: IC50 = 2.8 µM; PI 3-kinase p110 γ: IC50 = 37 µM; PI 3-kinase p110 δ: IC50 = 5.1 µM
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
9815659
Numero MDL :
MFCD00228054
SMILES :
C1COCCN1C2=CC(=C(C=C2)C=O)O

Download SDS (MSDS)

CERTIFICATO DI ANALISI

Adobe Acrobat Reader necessario per una visualizzazione affidabile,
stampa e commenta sui documenti PDF

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 127ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

La Santa Cruz Biotechnology, Inc. è un leader mondiale nello sviluppo di prodotti per il mercato della ricerca biomedica. Chiamaci al numero gratuito 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. Tutti i diritti riservati. "Santa Cruz Biotechnology", ed il logo Santa Cruz Biotechnology, Inc."Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", il logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", ed "EZ Touch" sono marchi registrati dalla Santa Cruz Biotechnology, Inc.
Tutti i marchi sono proprietà dei rispettivi proprietari.